Latest News

  • Alkermes Initiates Rolling Submission of ALKS 5461 New Drug Application for Major Depressive Disorder Read More
  • Corporate Response to Recent Media Articles About Alkermes and VIVITROL® Read More
  • Alkermes plc Reports Second Quarter 2017 Financial Results Read More

Investors

Learn more Learn More Alkermes PLC Investor Relations

Pipeline

See Out Approach See Our Approach Alkermes CNS Drug Development Pipeline

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes